Bloomberg - Home Search
Celgene Corp (CELG:US)
update Mar 27
118.68 +1.02 (+0.87%)
TODAY
High 120.00
Low 118.02
Open 118.11
Volume 5510401
Time Mar 27
intra-day chart
52 WEEK SUMMARY
High 129.06
Low 66.85
P/E 46.40
Return +70.41%
Mkt Cap 95.014 B
one year chart
Company Profile
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.